Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nirogacestat in Desmoid Tumors
NCT05879146Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nirogacestat in desmoid tumor, sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2024; status: recruiting.
02
Drugs
nirogacestat
03
Conditions
desmoid tumor
Beyond the preview
Go deeper on NCT05879146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05879146.